Letters to the Editor

Comorbidity indices for prognostic evaluation in multiple myeloma: a comprehensive evaluation of the Revised Myeloma Comorbidity Index and other comorbidity indices with pro- and retrospective applications

Department of Medicine I Hematology and Oncology, Medical Center -University of Freiburg, Faculty of Medicine, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center -University of Freiburg, Faculty of Medicine
Clinical Trials Unit, Medical Center -University of Freiburg, Faculty of Medicine
Department of Medicine I Hematology and Oncology, Medical Center -University of Freiburg, Faculty of Medicine, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center -University of Freiburg, Faculty of Medicine
Department of Medicine I Hematology and Oncology, Medical Center -University of Freiburg, Faculty of Medicine, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center -University of Freiburg, Faculty of Medicine
Department of Medicine I Hematology and Oncology, Medical Center -University of Freiburg, Faculty of Medicine, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center -University of Freiburg, Faculty of Medicine
Comprehensive Cancer Center Freiburg (CCCF), Medical Center -University of Freiburg, Faculty of Medicine, Germany; Department of Orthopedics and Trauma Surgery, Medical Center -University of Freiburg, Faculty of Medicine
Department of Medicine I Hematology and Oncology, Medical Center -University of Freiburg, Faculty of Medicine, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center -University of Freiburg, Faculty of Medicine
Department of Medicine I Hematology and Oncology, Medical Center -University of Freiburg, Faculty of Medicine, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center -University of Freiburg, Faculty of Medicine
Haematologica Early view Nov 30, 2023 https://doi.org/10.3324/haematol.2023.283884